Adalimumab Withdrawal in Uveitis Patients

Adalimumab is an effective treatment for JIA-associated uveitis and has been FDA approved for such use – but for how long and can the drug be withdrawn? An adalimumab (ADA) withdrawal trial has shown recurrence of uveitis, arthritis, or… https://t.co/J1CRgC3GJz https://t.co/8eOSvl5zZm